Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: Prospective cohort- and cross-sectional phenotyping studies

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Stefan, Norbert ^a,b,c   Sun, Qi ^d,e   Fritsche, Andreas ^a,b,c   Machann, JüRgen ^a,c   Schick, Fritz ^a   Gerst, Felicia ^a,b,c   Jeppesen, Charlotte ^c,f   Joost, Hans Georg ^c,f   Hu, Frank B ^d,e   Boeing, Heiner ^f   Ullrich, Susanne ^a,b,c   HäRing, Hans Ulrich ^a,b,c   Schulze, Matthias B ^c,f  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c Deutsches Zentrum Fü R Diabetesforschung DZD   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FETUIN A; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; AGED; BODY FAT DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FAT CONTENT; FAT MASS; FEMALE; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PHENOTYPE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; BLOOD; BODY MASS; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROSPECTIVE STUDIES; RISK; WAIST CIRCUMFERENCE;

EID: 84898670730     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092238     Document Type: Review

References (38)

1. Nolan CJ, Damm P, Prentki M (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378: 169-181.
2. Turer AT, Scherer PE (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55: 319-326.
3. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, et al. (2006) Adiponectin and adiponectin rec (Pubitemid 44033298)
4. Ouchi N, Parker JL, Lugus JJ, Walsh K (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 11: 85-97.
5. Roden M (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes- pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab. 2: 335-348. (Pubitemid 43885913)
6. Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, et al. (2007) Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133: 496-506. (Pubitemid 47187337)
7. Kotronen A, Yki-Järvinen H (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 28: 27-38.
8. Perseghin G (2011) Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. Diabetes Care 34 Suppl 2: S367-370.
9. Stefan N, Hä ring HU (2011) The metabolically benign and malignant fatty liver. Diabetes 60: 2011-2017.
10. Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142: 711-725.e6.
11. Stefan N, Hä ring HU (2013) The role of hepatokines in metabolism. Nat Rev Endocrinol. 9: 144-152.
12. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, et al. (2008) Fetuin- A and incident diabetes mellitus in older persons. JAMA300: 182-188. (Pubitemid 351969302)
13. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, et al. (2008) Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57: 2762-2767.
14. Ix JH, Biggs ML, Mukamal KJ, Kizer JR, Zieman SJ, et al. (2012) Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study. Circulation 125: 2316-2322.
15. Sun Q, Cornelis MC, Manson JE, Hu FB (2913) Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S. Diabetes 62: 49-55.
16. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, et al. (2008) Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118: 2555-2562.
17. Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, et al. (2009) Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2: 607-613.
18. Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, et al. (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58: 631-640. (Pubitemid 19210957)
19. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, et al. (2008) Fetuin- A induces cytokine expression and suppresses adiponectin production. PLoS One 3: e1765.
20. Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, et al. (2010) NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J. 429: 451-462.
21. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, et al. (2012) Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 18:1279-1285.
22. Stefan N, Hä ring HU (2013) Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 19: 394-395.
23. Heinrichsdorff J, Olefsky JM (2012) Fetuin-A: the missing link in lipid-induced inflammation. Nat Med. 18: 1182-1183.
24. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, et al. (2008) General and abdominal adiposity and risk of death in Europe. N Engl J Med. 359: 2105-2120.
25. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 168: 1609-1616.
26. Stefan N, Machicao F, Staiger H, Machann J, Schick F, et al. (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48: 2282-2291. (Pubitemid 41618919)
27. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197.
28. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470. (Pubitemid 29418240)
29. Rees DA, Alcolado JC (2012) Animal models of diabetes mellitus. Diabet Med. 22: 359-370.
30. Islam MS, Wilson RD (2012) Experimentally induced rodent models of type 2 diabetes. Methods Mol Biol. 933: 161-174.
31. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
32. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, et al. (2006) Alpha2- Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29: 853-857. (Pubitemid 44115306)
33. Reinehr T, Roth CL (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab. 93: 4479-4485. (Pubitemid 352789550)
34. Haukeland JW, Dahl TB, Yndestad A, Gladhaug IP, Løberg EM, et al. (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol. 166: 503-510.
35. Ou HY, Wu HT, Hung HC, Yang YC, Wu JS, et al. (2012) Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance. Endocrinology 153: 2974-2984.
36. Staiger K, Stefan N, Staiger H, Brendel MD, Brandhorst D, et al. (2005) Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta-cell lipoapoptosis. J Clin Endocrinol Metab. 90: 6707-6713. (Pubitemid 41759336)
37. Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev. 29: 42-61. (Pubitemid 351252746)
38. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379: 2279-2290.